​

Salarius Pharmaceuticals Ownership | Who Owns Salarius Pharmaceuticals?

OverviewRevenueFinancialsChart

Salarius Pharmaceuticals Ownership Summary

Salarius Pharmaceuticals is owned by 6.11% institutional investors, and 93.89% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.41% of its assets in Salarius Pharmaceuticals shares.

SLRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSalarius Pharmaceuticals6.11%-93.89%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202218-18.18%3,433,223-16.00%610.48%2-81.82%7133.33%
Jun 30, 202222-8.33%4,087,18812.60%712.40%1122.22%3-25.00%
Mar 31, 2022244.35%3,629,796-31.49%75.72%9-4-33.33%
Dec 31, 202123-8.00%5,298,252-21.04%115.22%9-35.71%6100.00%
Sep 30, 202125-13.79%6,709,810-33.66%142.93%147.69%3-66.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index5.85K0.41%2.83K
Horizon Kinetics Medical ETF3.72K0.26%-
Vanguard Institutional Extnd Mkt Idx Tr1.82K0.13%-
Fidelity Total Market Index321.000.02%-
Fidelity Series Total Market Index308.000.02%-
Fidelity Nasdaq Composite Index175.000.01%-
Northern Trust Extended Eq Market Idx170.000.01%-1.00
Spartan Total Market Index Pool E170.000.01%-
NT Ext Equity Mkt Idx Fd - L170.000.01%-1.00
NT Ext Equity Mkt Idx Fd - NL145.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 07, 2022Burleson Tess Buy$4.99K
Jun 07, 2022Lieber Jonathan I Buy$7.02K
Jun 06, 2022McVicar William K. Buy$5.00K
Jun 03, 2022HANISH ARNOLD C Buy$5.15K
Aug 21, 2020HANISH ARNOLD C-Buy$3.92K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q1--
2022 Q4--
2022 Q210-

SLRX Ownership FAQ

Who Owns Salarius Pharmaceuticals?

Salarius Pharmaceuticals shareholders are primarily institutional investors at 6.11%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Salarius Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Salarius Pharmaceuticals falls below.

Does Blackrock own Salarius Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Salarius Pharmaceuticals.

Who is the top mutual fund holder of Salarius Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Salarius Pharmaceuticals shares, with 0.41% of its total shares outstanding invested in 5.85K Salarius Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools